The stock of Neuronetics Inc (STIM) has gone down by -8.01% for the week, with a -5.63% drop in the past month and a 171.62% rise in the past quarter. The volatility ratio for the week is 10.71%, and the volatility levels for the past 30 days are 11.38% for STIM. The simple moving average for the past 20 days is -11.92% for STIM’s stock, with a 104.12% simple moving average for the past 200 days.
Is It Worth Investing in Neuronetics Inc (NASDAQ: STIM) Right Now?
Moreover, the 36-month beta value for STIM is 1.98. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for STIM is 34.67M and currently, short sellers hold a 8.03% of that float. On April 01, 2025, STIM’s average trading volume was 1.61M shares.
STIM) stock’s latest price update
The stock of Neuronetics Inc (NASDAQ: STIM) has increased by 9.24 when compared to last closing price of 3.68. Despite this, the company has experienced a -8.01% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-03-31 that Policy update increases access for millions covered by Evernorth Health Services Policy update increases access for millions covered by Evernorth Health Services
STIM Trading at -0.59% from the 50-Day Moving Average
After a stumble in the market that brought STIM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.09% of loss for the given period.
Volatility was left at 11.38%, however, over the last 30 days, the volatility rate increased by 10.71%, as shares sank -20.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +63.82% upper at present.
During the last 5 trading sessions, STIM fell by -7.78%, which changed the moving average for the period of 200-days by +99.50% in comparison to the 20-day moving average, which settled at $4.56. In addition, Neuronetics Inc saw 149.69% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at STIM starting from Furlong Stephen, who sale 1,867 shares at the price of $4.48 back on Mar 04 ’25. After this action, Furlong Stephen now owns 610,053 shares of Neuronetics Inc, valued at $8,364 using the latest closing price.
MACAN WILLIAM ANDREW, the EVP, GC, CCO and CS of Neuronetics Inc, sale 377 shares at $4.48 during a trade that took place back on Mar 04 ’25, which means that MACAN WILLIAM ANDREW is holding 526,805 shares at $1,689 based on the most recent closing price.
Stock Fundamentals for STIM
Current profitability levels for the company are sitting at:
- -0.45 for the present operating margin
- 0.72 for the gross margin
The net margin for Neuronetics Inc stands at -0.58. The total capital return value is set at -0.33. Equity return is now at value -139.60, with -33.66 for asset returns.
Based on Neuronetics Inc (STIM), the company’s capital structure generated 0.49 points at debt to capital in total, while cash flow to debt ratio is standing at -0.74. The debt to equity ratio resting at 0.97. The interest coverage ratio of the stock is -4.67.
Currently, EBITDA for the company is -34.04 million with net debt to EBITDA at -0.26. When we switch over and look at the enterprise to sales, we see a ratio of 3.66. The receivables turnover for the company is 3.08for trailing twelve months and the total asset turnover is 0.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.86.
Conclusion
To wrap up, the performance of Neuronetics Inc (STIM) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
